IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly
NCT02084095 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2019-08-21
Summary
Background Glucose metabolism abnormalities are frequent in acromegaly. Insulin resistance (IR) correlates with the intensity of acromegaly and Insulin-like Growth factor-I (IGF-I) correlates better with IR than growth hormone (GH). Insulin secretion (IS) is significantly reduced in hyperglycemic acromegalics as compared with those with normal glucose levels. IS is independent of acromegaly intensity.
The aim of this study is to show that in active acromegaly: 1) IGF-I does not cause IR but is just a better marker of acromegaly intensity than GH; 2) high GH levels induce IR through free fatty acids (FFA); 3) hyperglycemia is caused by a defficient IS on a background of IR.
Methods Intensity of acromegaly will be assessed using serum levels of GH, IGF-I and IGF binding globulin-3. IR and IS will be assessd using an intravenous glucose tolerance test acording to Bergman model. FFA will be directly measured in plasma.
Conditions
Sponsors & Collaborators
-
Carol Davila University of Medicine and Pharmacy
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2019-03-01
- Completion
- 2019-03-01
Countries
- Romania
Study Locations
More Related Trials
-
Diet in the Management of Acromegaly
NCT05401084 ·Status: RECRUITING ·Phase: NA
-
Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)
NCT01020955 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Study of Outcome After Therapy for Acromegaly
NCT01809808 ·Status: COMPLETED
-
Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.
NCT02092129 ·Status: UNKNOWN
-
Prospective Study on Changes in Acromegaly
NCT01612624 ·Status: UNKNOWN
-
Acromegaly: Patient And Physician Perspectives
NCT03613623 ·Status: COMPLETED
-
Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients
NCT01014793 ·Status: COMPLETED
-
The Treatment and Natural History of Acromegaly
NCT00001981 ·Status: COMPLETED
-
Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
NCT00647179 ·Status: COMPLETED
-
Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
NCT00703079 ·Status: COMPLETED
-
Brain-gut Interaction in Irradiated Patients With Acromegaly
NCT02005978 ·Status: UNKNOWN
-
Treatment Patterns and Treatment Outcomes for Acromegaly
NCT03043586 ·Status: COMPLETED
-
Reproducibility and Utility of OGTT in Acromegaly
NCT04066569 ·Status: COMPLETED ·Phase: NA
-
Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study
NCT05964712 ·Status: RECRUITING
-
Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly
NCT02115906 ·Status: UNKNOWN
-
Hypoproteic Diet in Acromegaly
NCT05298891 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Phase II Study With ITF2984 in Acromegalic Patients
NCT02111044 ·Status: COMPLETED ·Phase: PHASE2
-
GH and Cardiovascular Risk Factors
NCT01877512 ·Status: COMPLETED ·Phase: PHASE4
-
Peripheral Metabolic Effects of Somatostatin
NCT01062529 ·Status: COMPLETED ·Phase: NA
-
Surgical Versus Medical Treatment of Acromegaly
NCT01000090 ·Status: COMPLETED
-
KETOgenic Diet Therapy in Patients With ACROmegaly
NCT06949891 ·Status: RECRUITING ·Phase: NA
-
Strict IGF-1 Control in Acromegaly
NCT02952885 ·Status: COMPLETED ·Phase: PHASE3
-
Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
NCT02012127 ·Status: COMPLETED
-
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
NCT01568359 ·Status: COMPLETED
-
Inter-Assay Growth Hormone and IGF-I Variability
NCT00638287 ·Status: WITHDRAWN